Literature DB >> 2512290

Immunoglobulin kappa gene expression after stable integration. I. Role of the intronic MAR and enhancer in plasmacytoma cells.

V C Blasquez1, M Xu, S C Moses, W T Garrard.   

Abstract

Rearranged MOPC41 immunoglobulin kappa gene constructs have been stably introduced into cultured S194 mouse plasmacytoma cells to investigate the effects of deleting the intronic enhancer and/or matrix association region (MAR) on gene expression. Intact single-copy kappa genes containing 1.5 kilobase pairs of upstream and 8.5 kilobase pairs of downstream flanking sequences exhibited sensitivity to chromosome position effects and were expressed at a mean level of 27% relative to the endogenous kappa gene expression or only 6% with respect to the MOPC41 kappa mRNA levels in the tumor. Deletion of the intronic MAR led to a 4-fold decrease in expression, while deletion of both the MAR and enhancer led to an 11-fold decline. These effects were dampened by preselecting for integration into a transcriptionally poised chromatin location as demonstrated by linkage to a selectable marker which lacked both a MAR and an enhancer. Significantly, we found that sequences downstream of the poly(A) addition site compensated 150-fold for deletion of the intronic enhancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512290

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  The transcriptional enhancer of the pea plastocyanin gene associates with the nuclear matrix and regulates gene expression through histone acetylation.

Authors:  Yii Leng Chua; Lucy A Watson; John C Gray
Journal:  Plant Cell       Date:  2003-06       Impact factor: 11.277

2.  Spontaneous reactivation of a silent telomeric transgene in a human cell line.

Authors:  Joseph A Baur; Jerry W Shay; Woodring E Wright
Journal:  Chromosoma       Date:  2004-01-20       Impact factor: 4.316

3.  Nucleotide sequence of the intron of the germline human kappa immunoglobulin gene connecting the J and C regions reveals a matrix association region (MAR) next to the enhancer.

Authors:  C Whitehurst; H R Henney; E E Max; H W Schroeder; F Stüber; K A Siminovitch; W T Garrard
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

4.  Evaluation of sequence motifs found in scaffold/matrix-attached regions (S/MARs).

Authors:  I Liebich; J Bode; I Reuter; E Wingender
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

5.  Nuclear matrix attachment occurs in several regions of the IgH locus.

Authors:  P N Cockerill
Journal:  Nucleic Acids Res       Date:  1990-05-11       Impact factor: 16.971

6.  The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.

Authors:  K B Meyer; M J Sharpe; M A Surani; M S Neuberger
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

7.  Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.

Authors:  N E Wittekindt; K Hörtnagel; C Geltinger; A Polack
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

8.  Sequence-specific DNA-binding proteins are components of a nuclear matrix-attachment site.

Authors:  S I Dworetzky; K L Wright; E G Fey; S Penman; J B Lian; J L Stein; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

9.  DNA-PK-dependent binding of DNA ends to plasmids containing nuclear matrix attachment region DNA sequences: evidence for assembly of a repair complex.

Authors:  Stanley K Mauldin; Robert C Getts; Wenjing Liu; Thomas D Stamato
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

10.  A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.

Authors:  M C Roque; P A Smith; V C Blasquez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.